Screener
Corcept Therapeutics CORT Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from financing activities: | ||
| Proceeds from stock option exercises, net of issuance costs | 9,741 | 10,975 |
| Proceeds from purchases under the Employee Stock Purchase Program | 6,200 | 4,990 |
| Repurchases of common stock in connection with Stock Repurchase Program | — | (130,451) |
| Cash paid to satisfy statutory withholding requirement for net settlement of cashless option exercises and vesting of restricted stock grants | (17,218) | (28,251) |
| Net cash used in financing activities | (1,277) | (142,737) |
| Net effect of exchange rate changes on cash, cash equivalents and restricted cash | (250) | 1,794 |
| Net decrease in cash, cash equivalents and restricted cash | (9,456) | (24,920) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's share buybacks?
- Corcept Therapeutics (CORT) reported share buybacks of $0 in Q2 2026.
- How has Corcept Therapeutics's share buybacks changed year-over-year?
- Corcept Therapeutics's share buybacks decreased by 100.0% year-over-year, from $103.02M to $0.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about Corcept Therapeutics's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude